Breakthrough HIV infection on PrEP with injectable cabotegravir
6 August 2023. Related: HIV prevention and transmission.
CROI 30 (Retrovirus) 2023
30th CROI (CROI 2023): final reports
1 June 2023. Related: Conference reports.
Viral reservoir increases on long-term ART: new strategies for a cure
1 June 2023. Related: Conference reports, Cure research.
Microbiota biomarkers might predict risk of HSIL progression: succinyl-CoA and cobalamin
1 June 2023. Related: Conference reports, Cancer and HIV.
CROI overviews by BHIVA and IAS-USA
1 June 2023. Related: Conference reports.
30th CROI (CROI 2023): further reports
6 April 2023. Related: Conference reports.
Implications of restrictions on reproductive rights for HIV care in the USA and beyond
6 April 2023. Related: Conference reports, Treatment access, Women's health, Pregnancy.
30th Conference on Retroviruses and OIs (CROI 2023): first reports
10 March 2023. Related: Conference reports.
CROI 2023: Pipeline HIV drugs and formulations for treatment and PrEP
10 March 2023. Related: Conference reports, Antiretrovirals.
CROI 2023: Six-monthly ART – lenacapavir + dual bNAbs maintains undetectable viral load for 26 weeks after single doses
10 March 2023. Related: Conference reports, Antiretrovirals.
CROI 2023: Other lenacapavir studies – experienced and naive updates, the dosing window, HIV-2 and PrEP
10 March 2023. Related: Conference reports, Antiretrovirals.
CROI 2023: Similar PK profile for thigh vs gluteal CAB/RPV-LA injections: accidental intravenous injection
10 March 2023. Related: Conference reports, Antiretrovirals.
CROI 2023: Efficacy of N6LS monotherapy correlated with baseline factors
10 March 2023. Related: Conference reports, Antiretrovirals.
CROI 2023: CAB/RPV-LA levels are not reduced after switching from efavirenz
10 March 2023. Related: Conference reports, PK and drug interactions.
CROI 2023: Yet more evidence for recycled tenofovir and 3TC or FTC with dolutegravir in second-line: 48 week results from the D2EFT study
10 March 2023. Related: Conference reports, Treatment strategies, Drug resistance.
CROI 2023: Point-of-care testing for mothers and infants: results from the LIFE study
10 March 2023. Related: Conference reports, Pregnancy, Paediatric care.